Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD19 binding agent FDA PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Large B-Cell, Diffuse 4 D016403 ClinicalTrials
Lymphoma, B-Cell 4 D016393 FDA
Lymphoma, Follicular 2 D008224 ClinicalTrials
Lymphoma, Follicular 2 D008224 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 D054198 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297778
FDA SRS 7K5O7P6QIU